These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21371011)

  • 1. The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.
    Wierońska JM; Kusek M; Tokarski K; Wabno J; Froestl W; Pilc A
    Br J Pharmacol; 2011 Jul; 163(5):1034-47. PubMed ID: 21371011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous activation of muscarinic and GABA
    Cieślik P; Woźniak M; Tokarski K; Kusek M; Pilc A; Płoska A; Radulska A; Pelikant-Małecka I; Żołnowska B; Sławiński J; Kalinowski L; Wierońska JM
    Behav Brain Res; 2019 Feb; 359():671-685. PubMed ID: 30267715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022.
    Woźniak M; Acher F; Marciniak M; Lasoń-Tyburkiewicz M; Gruca P; Papp M; Pilc A; Wierońska JM
    Curr Neuropharmacol; 2016; 14(5):413-26. PubMed ID: 26769224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine.
    Lhuillier L; Mombereau C; Cryan JF; Kaupmann K
    Neuropsychopharmacology; 2007 Feb; 32(2):388-98. PubMed ID: 16710312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents.
    Pałucha-Poniewiera A; Kłodzińska A; Stachowicz K; Tokarski K; Hess G; Schann S; Frauli M; Neuville P; Pilc A
    Neuropharmacology; 2008 Sep; 55(4):517-24. PubMed ID: 18619473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats.
    Vlachou S; Paterson NE; Guery S; Kaupmann K; Froestl W; Banerjee D; Finn MG; Markou A
    Eur J Pharmacol; 2011 Mar; 655(1-3):52-8. PubMed ID: 21262222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mGlu₅-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia.
    Wierońska JM; Kłeczek N; Woźniak M; Gruca P; Łasoń-Tyburkiewicz M; Papp M; Brański P; Burnat G; Pilc A
    Neurochem Int; 2015 Sep; 88():97-109. PubMed ID: 25863284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents.
    Sławińska A; Wierońska JM; Stachowicz K; Marciniak M; Lasoń-Tyburkiewicz M; Gruca P; Papp M; Kusek M; Tokarski K; Doller D; Pilc A
    Br J Pharmacol; 2013 Aug; 169(8):1824-39. PubMed ID: 23714045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats.
    Orrù A; Lai P; Lobina C; Maccioni P; Piras P; Scanu L; Froestl W; Gessa GL; Carai MA; Colombo G
    Eur J Pharmacol; 2005 Nov; 525(1-3):105-11. PubMed ID: 16289452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior.
    Mombereau C; Kaupmann K; Froestl W; Sansig G; van der Putten H; Cryan JF
    Neuropsychopharmacology; 2004 Jun; 29(6):1050-62. PubMed ID: 15039762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.
    Maccioni P; Zaru A; Loi B; Lobina C; Carai MA; Gessa GL; Capra A; Mugnaini C; Pasquini S; Corelli F; Hyytiä P; Lumeng L; Colombo G
    Alcohol Clin Exp Res; 2012 Oct; 36(10):1748-66. PubMed ID: 22486245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of GABAB receptor ligands in rodent tests of anxiety-like behavior.
    Partyka A; Kłodzińska A; Szewczyk B; Wierońska JM; Chojnacka-Wójcik E; Librowski T; Filipek B; Nowak G; Pilc A
    Pharmacol Rep; 2007; 59(6):757-62. PubMed ID: 18195467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function.
    Urwyler S; Pozza MF; Lingenhoehl K; Mosbacher J; Lampert C; Froestl W; Koller M; Kaupmann K
    J Pharmacol Exp Ther; 2003 Oct; 307(1):322-30. PubMed ID: 12954816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivo.
    Gjoni T; Desrayaud S; Imobersteg S; Urwyler S
    J Neurochem; 2006 Mar; 96(5):1416-22. PubMed ID: 16441514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward.
    Halbout B; Quarta D; Valerio E; Heidbreder CA; Hutcheson DM
    Addict Biol; 2011 Jul; 16(3):416-27. PubMed ID: 21309927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats.
    Paterson NE; Vlachou S; Guery S; Kaupmann K; Froestl W; Markou A
    J Pharmacol Exp Ther; 2008 Jul; 326(1):306-14. PubMed ID: 18445779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties.
    Urwyler S; Gjoni T; Koljatić J; Dupuis DS
    Neuropharmacology; 2005 Mar; 48(3):343-53. PubMed ID: 15721166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms.
    Gannon RL; Millan MJ
    Pharmacol Biochem Behav; 2011 Oct; 99(4):712-7. PubMed ID: 21756929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
    Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
    Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutations in the transmembrane region of GABAB2 facilitate activation by the positive modulator N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) in the absence of the GABAB1 subunit.
    Dupuis DS; Relkovic D; Lhuillier L; Mosbacher J; Kaupmann K
    Mol Pharmacol; 2006 Dec; 70(6):2027-36. PubMed ID: 16966477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.